Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

LXR files IDE with FDA for heart preservation solution

Oct. 14, 1997

Yoshitomi licenses immunosuppressant to Novartis

Oct. 13, 1997

Aviron updates vaccine clinical program

Oct. 10, 1997

Therapeutic Antibodies' CytoTAb enters clinical trials

Oct. 7, 1997

MOMP DNA immunization for chlamydial infections

Oct. 6, 1997

OraVax to market and distribute Evans Medical's yellow fever vaccine

Oct. 3, 1997

North American Vaccine advances with meningitis B vaccine

Oct. 2, 1997

Collaborators demonstrate protection against HSV with Cel-Sci vaccine

Oct. 1, 1997

LF-08-0299 both prevents and reverses kidney rejection in dogs

Sep. 30, 1997

FTY-720: novel immunosuppressant for combination therapy

Sep. 25, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...